Exicure, Inc. (XCUR)
1.02
0.00 (0.00%)
USD |
NASDAQ |
Oct 08, 12:17
Exicure Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 59.80% |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 97.90% |
| September 30, 2022 | 76.98% |
| June 30, 2022 | 81.26% |
| March 31, 2022 | 88.23% |
| December 31, 2021 | 78.23% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -747.8% |
| Celularity, Inc. | 20.70% |
| Cardio Diagnostics Holdings, Inc. | -824.1% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -181.7% |
| Return on Assets | -56.73% |
| Return on Invested Capital | -173.8% |
| Return on Net Operating Assets | -93.61% |